© 2021 MJH Life Sciences and Contemporary Pediatrics. All rights reserved.
© 2021 MJH Life Sciences™ and Contemporary Pediatrics. All rights reserved.
September 09, 2021
The European Commission has granted an expanded approval to ravulizumab-cwvz to include children with a body weight of at least 10 kg, as well as adolescents, with paroxysmal nocturnal hemoglobinuria.
August 31, 2021
For most of the pandemic, COVID-19 has been mild in children. Has this been true for children with underlying health conditions, in particular cancer?